As initial bafflement over the coronavirus pandemic ebbs away, advances are being made to combat the new disease. Experts debate promising antidotes and evaluate imaging modalities for COVID-19. This is bolstered by a resilient infrastructure – maintaining tight IT security in hospitals extends infection control to the digital realm.
Enjoy browsing!
 |
Article • Coronavirus disease researchSeeking a COVID-19 antidote: the potential of ACE2As coronavirus disease COVID-19 continues to jet and alight invisibly around the globe, scientists now report that the virus has mutated to become two strains: the older ‘S-type’ appears milder and less infectious, while the later-emerging ... |
 |
Sponsored • Endoscope dryingEmpowering Reprocessing Staff: Improving Patient SafetyHuman factor aspects of reprocessing can never be completely avoided yet staff can be empowered to reduce the risk of infection. This was an important conclusion established at a multidisciplinary expert panel held at Pentax Medical’s R&D ... |
 |
Interview • Chest X-ray, CT and moreImaging the coronavirus disease COVID-19Chest X-ray is the first imaging method to diagnose COVID-19 coronavirus infection in Spain, but in the light of new evidence this may change soon, according to Milagros Martí de Gracia, Vice President of the Spanish Society of Radiology (SERAM) ... |
 |
Article • Bringing AI to the clinicsPioneering a vendor neutral AI systemCapturing all the possibilities brought by AI long-seemed a faraway dream for hospitals, since most artificial intelligence (AI) solutions are vendor dependent, thus complicating their deployment in clinical practice. However, the dream has become ... |
 |
Article • Raising data protection levels against cyberattacksIT security: as routine as disinfectionCyber attacks on hospitals occur every day. However, if IT security works well, nobody needs even notice. But if defence measures fail the impact can be enormous and the outcry among the general public large. The new branch-specific security ... |
 |
News • Pharma for the peopleIs it time to nationalise the drug industry?Critics of the pharmaceutical industry say it is misaligned with public interest. So is it time to nationalise the sector? Experts debate the issue in The BMJ today. Mariana Mazzucato and Henry Lishi Li at the UCL Institute for Innovation & ... |
You are receiving this email because you subscribed to our newsletter on healthcare-in-europe If you don’t want to receive this newsletter anymore, click here to unsubscribe. Keep up-to-date on the latest news from all hospital-related fields! Copyright © 2024 mgo fachverlage GmbH & Co. KG. E.-C.-Baumann-Straße 5, 95326 Kulmbach, Germany |
   |